Moderna Inc Cash Flow Reinvestment Rate
Moderna Inc cash flow reinvestment rate. Moderna Inc (MRNA) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $48.00 Million (capex $39.00 Million plus investments $-9.00 Million) from operating cash flow of $951.00 Million. See Moderna Inc (MRNA) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Moderna Inc (2016–2022)
Cash flow reinvestment rate of Moderna Inc from 2016 to 2022. Historical reinvestment intensity for Moderna Inc across 4 annual periods. Explore MRNA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Moderna Inc Cash Flow Reinvestment Rate by Year (2016–2022)
Moderna Inc cash flow reinvestment rate by year from 2016 to 2022. Year-by-year capital reinvestment analysis for Moderna Inc. For the full cash flow conversion analysis, see MRNA cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.12x | $5.58 Billion | $4.98 Billion | $400.00 Million | ▲ +78.9% |
| 2021 | 0.63x | $8.52 Billion | $13.62 Billion | $284.00 Million | ▼ -24.1% |
| 2020 | 0.82x | $1.67 Billion | $2.03 Billion | $67.45 Million | ▼ -91.9% |
| 2016 | 10.22x | $681.75 Million | $66.73 Million | $33.14 Million | — |